Also interesting
![PR caption](https://www.kickstartbiomanufacturing.be/assets/uploads/site/_767x490_crop_center-center_95_none/PR-caption.jpg)
Visit of the Belgian sovereigns Philippe and Mathilde to Afrigen Biologics
During their state visit to South Africa last March, Queen Mathilde and King Philippe visited the Afrigen biologics facilities in Cape Town to learn more about how two Belgian companies, Univercells and Etherna, are supporting the development of the first African-owned mRNA COVID-19 vaccine to further discuss cooperation and partnership between the two countries and focus, among other things, on business and development.
![GSK INV 760x400](https://www.kickstartbiomanufacturing.be/assets/uploads/site/_767x490_crop_center-center_95_none/GSK-INV-760x400.jpeg)
GSK continues to invest heavily in Belgium at its sites in Wavre and Rixensart
The British pharmaceutical company GSK continues to invest in its production site in Wavre and its research and development site in Rixensart...
![Univercells image B mid size 760x400](https://www.kickstartbiomanufacturing.be/assets/uploads/site/_767x490_crop_center-center_95_none/Univercells-image-B-mid-size-760x400.jpeg)
Univercells builds two production plants in Jumet
The biotechnology company Univercells is setting up its subsidiary Exothera in Jumet, on the former site of the IT company Systemat, to offer complete development and manufacturing services for viral vectors for the development of vaccines and gene therapies...